Please assess the completion status of the following clinical trial:

Trial Title: Midazolam Effect in Children Undergoing Voiding Cystourethrogram (VCUG)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 2-6 years~* Toilet trained~* English speaking~* Already scheduled for VCUG~Exclusion Criteria:~* Allergic to midazolam~* Active UTI~* Known urethral stricture~* Known urethral reconstruction~* Has history of abnormal sensation in pelvic area~* Has history of sexual abuse~* Has severe developmental delay~* Has diagnosis of anxiety disorders

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 6 Years
- Healthy Volunteers: t

Study Arms:
- Versed (Type: EXPERIMENTAL): Both patients who are VCUG naive and patients who have had a previous VCUG are given oral midazolam prior to undergoing the VCUG.
- Placebo (Type: PLACEBO_COMPARATOR): Both patients who are VCUG naive and patients who have had a previous VCUG are given an oral placebo prior to undergoing the VCUG.

Based on this trial design, predict the completion outcome and termination type (if applicable).